What Researchers Did
This study investigated how combining Enhanced External Counterpulsation (EECP) and Hyperbaric Oxygen Therapy (HBOT) affects heart function and patient outcomes in 100 adults with ischaemic cardiomyopathy.
What They Found
The study found significant improvements in heart function, with left ventricular ejection fraction (LVEF) increasing from 34.17% to 41.43% (p<0.001). Patients also showed better exercise capacity, with a 6-minute walk test distance increasing from 243.7 meters to 367.4 meters (p<0.001), and their heart failure symptoms (NYHA class) improved from severe to mainly mild (p<0.001). Other markers like global longitudinal strain and NT-proBNP also improved significantly.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
A key limitation is that these are interim results from an ongoing study, meaning the long-term benefits and safety of this combined therapy are still being evaluated.